Skip metastases in medullary thyroid carcinoma: A single-center experience

Surgery Today

Volumn 38, Issue 6, 2008, Pages 499-504

  Tavares, Marcos R ^a   Michaluart Jr , Pedro ^a   Montenegro, Fabio ^a   Arap, Sergio ^a   Sodre, Maria ^a   Takeda, Flavio ^a   Brandao, Lenine ^a   Toledo, Sergio ^a   Ferraz, Alberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Lymph node metastasis; Medullary carcinoma; Medullary surgery; Neck dissection; Thyroid neoplasm

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; INCIDENCE; LYMPH NODE METASTASIS; MALE; MEDICAL RECORD; NECK DISSECTION; NECK METASTASIS; PREDICTION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME;

EID: 44449156392     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-007-3664-8     Document Type: Article

References (17)

1. Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma. Recommendations for extent of node dissection. Ann Surg 1999;229:880-888.
2. Weber T, Schilling T, Frank-Raue K, Colombo-Benkmann M, Hinzuziegler R, Klar E. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery 2001;130:1044-1049.
3. Dralle H, Scheumann GF, Proye C, Bacourt F, Frilling A, Limbert F, et al. The value of lymph node dissection in hereditary medullary thyroid carcinoma: a retrospective, European, multicentre study. J Intern Med 1995;238:357-361.
4. Brandi ML, Gagel RF, Angeli A, Bilenzikian PB, Bordi C, Conte-Devolx, B, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001;86: 5568-5571.
5. Wells S Jr, Chi DD, Toshima K, Dehner, LP, Coffin CM, Dowton B, et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994;220:237-247.
6. Sanso GE, Domene HM, Garcia R, Pusiol EM, Roque M, Ring A, et al. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Cancer 2001;94:323-330.
7. Hyer SL, Vini L, A'hern R, Harmer C. Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. Eur J Surg Oncol 2000;26:686-690.
8. Buhr HJ, Kallinowski F, Raue F, Frank-Raue K, Herfarth C. Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma. Three-year results. Cancer 1993;72:3685-3693.
9. Machens A, Gimm O, Ukkat J, Sutter T, Dralle H. Repeat mediastinal lymph-node dissection for palliation in advanced medullary thyroid carcinoma. Langenbecks Arch Surg 1999;384:271-276.
10. Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, et al. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 2003;88:2070-2075.
11. Ellenhorn JDI, Shah JP, Brennan MF. Impact of therapeutic regional lymph node dissection for medullary carcinoma of the thyroid gland. Surgery 1993;114:1078-1082.
12. Raue F. German medullary thyroid carcinoma/multiple endocrine neoplasia registry. German MTC/MEN Study Group. Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia Type 2. Arch Surg 1998;383:334-336.
13. Moley JF, DeBenedetti MK, Dilley WG, Tisell LE, Wells SA Jr. Surgical management of patients with persistent or recurrent medullary thyroid cancer. J Intern Med 1998;243:521-526.
14. Gimm O, Ukkat J, Dralle H. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J Surg 1998;22:562-568.
15. Sasson AR, Pingpank JF Jr, Wetherington RW, Hanlon AL, Ridge JA. Incidental parathyroidectomy during thyroid surgery does not cause transient symptomatic hypocalcemia. Arch Otolaryngol Head Neck Surg 2001;127(3):304-308.
16. Khoo MLC, Freeman JL. Transcervical superior mediastinal lymphadenectomy in the management of papillary thyroid carcinoma. Head Neck 2003;25:10-14.
17. Kebebew E, Ituarte PH, Siperstein AE, Duh QY, Clark OH. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer 2000;88:1139-1148.